Abbott (NYSE:ABT) is launching a new initiative that takes a look at some of the stigmas and stereotypes that come with ...
GlobalData on MSN6d
Beta Bionics raises $204m to kickstart medtech IPO seasonBeta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its anticipated target. The US-based company sold 12 million shares of its common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback